EMA publishes agenda for 10-13 November 2025 CHMP meeting

EMA

10 November 2025 - The EMA has published a draft agenda for this week's CHMP meeting.

The CHMP is due to issue opinions for the following technologies:

  • Donidalorsen
  • Enzalutamide
  • Germanium (Ge 68) chloride/Gallium (Ga 68) chloride
  • Insulin glargine
  • Denosumab
  • Teplizumab
  • Pertussis vaccine (acellular)
  • Autologous CD34+ haematopoietic stem cells transduced ex vivo with a lentiviral vector encoding human Wiskott-Aldrich syndrome protein

Read CHMP agenda 

Michael Wonder

Posted by:

Michael Wonder